Fountain Therapeutics
PrivateLast Round
Series B
Aug 13, 2025
Total Funding Raised
$44M
Company Overview
Fountain Therapeutics is a biotechnology company that develops targeted therapeutics to reverse cellular aging and treat age-related diseases using an artificial intelligence-driven drug discovery platform.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fountain Therapeutics Comparables
Compare Fountain Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gero | 82% | |
| Recursion Pharmaceuticals | 80% | |
| Verge Labs | 77% | |
Fountain Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 13, 2025 | ||||
| Series A Extension | Nov 18, 2021 | ||||
| Series A Extension | May 19, 2020 | ||||
| Series A | May 1, 2018 |
Fountain Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Series A Extension |
| Nan Fung Life Sciences | Series A Extension, Series A |
| EOS Ventures | Series B |
| Alexandria Venture Investments | Series A Extension |
| R42 Group | Series A Extension |
| Alexandria Venture Investments | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 18, 2021
$15M raised with participation from Khosla Ventures.
- May 1, 2018
$5M round led by Nan Fung Life Sciences
Fountain Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Fountain Therapeutics's valuation, stock price, and market status.